06.02.2020
Emergent Continues to Expand Role in Support of Development and Manufacturing of COVID-19 Vaccines
Emergent BioSolutions recently announced that it has been issued a task order under an existing contract with the Biomedical...
06.02.2020
Emergent BioSolutions recently announced that it has been issued a task order under an existing contract with the Biomedical...
04.27.2020
GAITHERSBURG, Md., April 23, 2020 (GLOBE NEWSWIRE)
Emergent BioSolutions Inc. (NYSE:EBS) today announced an agreement whereby...
03.23.2020
Original news coverage of Novavax's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...
03.23.2020
Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...